Sarah Crunkhorn. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Chondroitinsulfatases/therapeutic useClinical Trials, Phase III as TopicDrug IndustryEnzyme Replacement TherapyHumansMucopolysaccharidosis IV/drug therapyMucopolysaccharidosis IV/enzymology
Substances: See more » ChondroitinsulfatasesGALNS protein, human
Year: 2013 PMID: 23274460 DOI: 10.1038/nrd3929
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN: 1474-1776 Impact factor: 84.694